Log in

Relevant bibliographies by topics / Interleukin-12 / Journal articles

To see the other types of publications on this topic, follow the link: Interleukin-12.

Journal articles on the topic 'Interleukin-12'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Interleukin-12.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Leonard, Patricia, and Sanjiv Sur. "Interleukin-12." BioDrugs 17, no. 1 (2003): 1–7. http://dx.doi.org/10.2165/00063030-200317010-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

&NA;. "Interleukin-12." Inpharma Weekly &NA;, no. 1124 (1998): 7. http://dx.doi.org/10.2165/00128413-199811240-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Trinchieri, Giorgio. "Interleukin-12." Clinical Immunotherapeutics 3, no. 4 (1995): 262–70. http://dx.doi.org/10.1007/bf03259278.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Clinton, Steven K., Eduardo Canto, and Michael A. O'Donnell. "INTERLEUKIN-12." Urologic Clinics of North America 27, no. 1 (2000): 147–55. http://dx.doi.org/10.1016/s0094-0143(05)70242-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Weiner, David. "Plasmid Interleukin 12." AIDS 14, no. 12 (2000): 1759–60. http://dx.doi.org/10.1097/00002030-200008180-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Leng, S. X., and J. A. Elias. "Interleukin-11 inhibits macrophage interleukin-12 production." Journal of Immunology 159, no. 5 (1997): 2161–68. http://dx.doi.org/10.4049/jimmunol.159.5.2161.

Full text

Abstract:

Abstract IL-12 is a heterodimeric cytokine produced by phagocytic and other cells with important physiologic and pathologic properties. Regulated IL-12 production is crucial for the generation of protective Th1 responses to infectious agents. In contrast, IL-12 excess contributes to the pathogenesis of a variety of autoimmune and inflammatory disorders. To further understand the processes regulating IL-12 production, we determined whether IL-11 regulated monocyte/macrophage production of this cytokine moiety. IL-11 did not alter the IL-12 (p70) production of unstimulated THP-1 monocytic cells

APA, Harvard, Vancouver, ISO, and other styles

7

Fox, Robert J., and Abdolmohamad M. Rostami. "Anti???Interleukin-12 Antibody." BioDrugs 13, no. 4 (2000): 233–41. http://dx.doi.org/10.2165/00063030-200013040-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

&NA;. "Interleukin-12 trial halted." Reactions Weekly &NA;, no. 556 (1995): 2. http://dx.doi.org/10.2165/00128415-199505560-00003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

&NA;. "Interleukin-12 studies continue." Reactions Weekly &NA;, no. 558 (1995): 2. http://dx.doi.org/10.2165/00128415-199505580-00003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

&NA;. "Interleukin-12 trial halted." Inpharma Weekly &NA;, no. 992 (1995): 21. http://dx.doi.org/10.2165/00128413-199509920-00047.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

&NA;. "Interleukin-12 studies continue." Inpharma Weekly &NA;, no. 994 (1995): 21. http://dx.doi.org/10.2165/00128413-199509940-00042.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

KATIYAR, S. "Interleukin-12 and photocarcinogenesis." Toxicology and Applied Pharmacology 224, no. 3 (2007): 220–27. http://dx.doi.org/10.1016/j.taap.2006.11.017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Maguire, H. C. "INTERLEUKIN 12 AS IMMUNOADJUVANT." Journal of Immunotherapy 16, no. 3 (1994): 240. http://dx.doi.org/10.1097/00002371-199410000-00032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

de Rie, M. A. "Interleukin 12 and Psoriasis." Dermatology 199, no. 2 (1999): 101. http://dx.doi.org/10.1159/000018213.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Trinchieri, Giorgio, and Franca Gerosa. "Immunoregulation by interleukin-12." Journal of Leukocyte Biology 59, no. 4 (1996): 505–11. http://dx.doi.org/10.1002/jlb.59.4.505.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Ma, X., A. D'Andrea, M. Kubin, et al. "Production of interleukin-12." Research in Immunology 146, no. 7-8 (1995): 432–38. http://dx.doi.org/10.1016/0923-2494(96)83012-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Crutcher, J. M., M. M. Stevenson, M. Sedegah, and S. L. Hoffman. "Interleukin-12 and malaria." Research in Immunology 146, no. 7-8 (1995): 552–59. http://dx.doi.org/10.1016/0923-2494(96)83031-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Tsai, I. San, Chi-Cheng Tsai, Ya-Ping Ho, Kun-Yen Ho, Yi-Min Wu, and Chun-Cheng Hung. "Interleukin-12 and interleukin-16 in periodontal disease." Cytokine 31, no. 1 (2005): 34–40. http://dx.doi.org/10.1016/j.cyto.2005.02.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

BACON, CHRIS M., SARAH S. CHO, and JOHN J. O'SHEA. "Signal Transduction by Interleukin-12 and Interleukin-2." Annals of the New York Academy of Sciences 795, no. 1 Interleukin 1 (1996): 41–59. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52654.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Torti, Dorothea C., and Steven R. Feldman. "Interleukin-12, interleukin-23, and psoriasis: Current prospects." Journal of the American Academy of Dermatology 57, no. 6 (2007): 1059–68. http://dx.doi.org/10.1016/j.jaad.2007.07.016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Sánchez, E., S. Morales, L. Paco, et al. "Interleukin 12 (IL12B), interleukin 12 receptor (IL12RB1) and interleukin 23 (IL23A) gene polymorphism in systemic lupus erythematosus." Rheumatology 44, no. 9 (2005): 1136–39. http://dx.doi.org/10.1093/rheumatology/keh697.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Orozco, Gisela, Miguel A. González-Gay, Laura Paco, et al. "Interleukin 12 (IL12B) and Interleukin 12 Receptor (IL12RB1) Gene Polymorphisms in Rheumatoid Arthritis." Human Immunology 66, no. 6 (2005): 710–14. http://dx.doi.org/10.1016/j.humimm.2005.02.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Mattner, Frank, Susanne Fischer, Stefanie Guckes, et al. "The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer." European Journal of Immunology 23, no. 9 (1993): 2202–8. http://dx.doi.org/10.1002/eji.1830230923.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Eman, Arif Rahman, Vitayani Muchtar Sri, Tabri Farida, et al. "EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY." International Journal of Medical Reviews and Case Reports 2, no. 4 (2018): 161–65. https://doi.org/10.5455/IJMRCR.MULTIBACILLARY-TYPE-LEPROSY-INTERLEUKINS.

Full text

Abstract:

Background: Leprosy is a chronic infectious disease caused by Mycobacterium leprae. In leprosy, cell-mediated immune responses are an important aspect of host resistance to mycobacterial infections and allegedly governed by anequilibrium between type 1 cytokines including Interleukin-12 (IL-12); with type 2 cytokines such as Interleukin-4 (IL-4). Currently, the World Health Organization (WHO) recommends 3 leprosy treatment regimens, one of them is Rifampicin Ofloxacin Minocycline (ROM). To date, studies on the effects of ROM on leprosy have been limited, none have specifically assessed the eff

APA, Harvard, Vancouver, ISO, and other styles

25

Lu, Zhiyu, Keye Xu, Xiaoying Wang, Yan Li, and Mingcai Li. "Interleukin 39: a new member of interleukin 12 family." Central European Journal of Immunology 45, no. 2 (2020): 214–17. http://dx.doi.org/10.5114/ceji.2020.97911.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Rentzos, M., C. Nikolaou, E. Andreadou, et al. "Circulating interleukin-10 and interleukin-12 in Parkinson’s disease." Acta Neurologica Scandinavica 119, no. 5 (2009): 332–37. http://dx.doi.org/10.1111/j.1600-0404.2008.01103.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Tahara, H., L. Zitvogel, W. J. Storkus, T. G. McKinney, P. D. Robbins, and M. T. Lotze. "CANCER GENE THERAPY USING INTERLEUKIN-12 (IL-12)." Journal of Immunotherapy 16, no. 3 (1994): 245. http://dx.doi.org/10.1097/00002371-199410000-00053.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

&NA;. "Interleukin-12 toxicity mystery solved." Reactions Weekly &NA;, no. 580 (1995): 2. http://dx.doi.org/10.2165/00128415-199505800-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

&NA;. "Interleukin-12 toxicity mystery solved." Inpharma Weekly &NA;, no. 1016 (1995): 21. http://dx.doi.org/10.2165/00128413-199510160-00046.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Romani, L., P. Puccetti, and F. Bistoni. "Interleukin-12 in infectious diseases." Clinical Microbiology Reviews 10, no. 4 (1997): 611–36. http://dx.doi.org/10.1128/cmr.10.4.611.

Full text

Abstract:

Interleukin-12 (IL-12) is a potent immunoregulatory cytokine that is crucially involved in a wide range of infectious diseases. In several experimental models of bacterial, parasitic, viral, and fungal infection, endogenous IL-12 is required for early control of infection and for generation and perhaps maintenance of acquired protective immunity, directed by T helper type 1 (Th1) cells and mediated by phagocytes. Although the relative roles of IL-12 and gamma interferon in Th1-cell priming may be to a significant extent pathogen dependent, common to most infections is that IL-12 regulates the

APA, Harvard, Vancouver, ISO, and other styles

31

Romani, L., P. Puccetti, and F. Bistoni. "Interleukin-12 in infectious diseases." Clinical microbiology reviews 10, no. 4 (1997): 611–36. http://dx.doi.org/10.1128/cmr.10.4.611-636.1997.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Bashyam, Hema. "Interleukin-12: A master regulator." Journal of Experimental Medicine 204, no. 5 (2007): 969. http://dx.doi.org/10.1084/jem.2045fta.

Full text

Abstract:

Early resistance to pathogens requires a swift response from NK cells. In 1989, Giorgio Trinchieri identified an NK growth factor and activator, later called interleukin-12 (IL-12). This discovery helped reveal the regulatory link between innate and adaptive immunity.

APA, Harvard, Vancouver, ISO, and other styles

33

Adorini, Luciano. "Interleukin 12 and autoimmune diabetes." Nature Genetics 27, no. 2 (2001): 131–32. http://dx.doi.org/10.1038/84732.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Bubeník, Jan. "Interleukin 12 in Cancer Treatment." Folia Biologica 57, no. 1 (2011): 1–2. http://dx.doi.org/10.14712/fb2011057010001.

Full text

Abstract:

Interleukin 12 (IL-12) is made up of two disulphidelinked chains, p35 and p40. The cytokine is produced by monocytes, macrophages, myeloid dendritic cells and B cells. It stimulates development of NK cells and TH1 differentiation of CD4+ T cells, thus participating in the regulation of the immune response (for a review, see Klein and Hořejší, 1997; Grufman and Kärre, 2000; Jinushi and Tahara, 2009). Recently, the structurally similar but functionally different cytokine IL-23 displaying anti-tumour effects and related to the IL-12 family of cytokines was discovered (Engel and Neurath, 2010). In

APA, Harvard, Vancouver, ISO, and other styles

35

Sacks, G. P., D. Scott, H. Tivnann, T. Mire-Sluis, I. L. Sargent, and C. W. G. Redman. "Interleukin-12 and pre-eclampsia." Journal of Reproductive Immunology 34, no. 2 (1997): 155–58. http://dx.doi.org/10.1016/s0165-0378(97)00028-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Bryan, Dani-Louise, Joanna S. Hawkes, and Robert A. Gibson. "Interleukin-12 in Human Milk." Pediatric Research 45, no. 6 (1999): 858–59. http://dx.doi.org/10.1203/00006450-199906000-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Sturmhoefel, K., K. Lee, M. O. Toole, H. M. Swiniarski, A. J. Dorner, and S. F. Wolf(xc*). "Interleukin 12 as vaccine adjuvant." Research in Immunology 149, no. 1 (1998): 37–39. http://dx.doi.org/10.1016/s0923-2494(98)80041-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Rowe, PaulM. "Cautious optimism over interleukin-12." Lancet 345, no. 8962 (1995): 1432. http://dx.doi.org/10.1016/s0140-6736(95)92618-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Trinchieri, Giorgio, Manthrasalam Rengaraju, Annalisa D'Andrea, et al. "Producer cells of interleukin-12." Immunology Today 14, no. 5 (1993): 237–38. http://dx.doi.org/10.1016/0167-5699(93)90173-i.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

MA, XIAOJING, MIGUEL ASTE-AMEZAGA, and GIORGIO TRINCHIERI. "Regulation of Interleukin-12 Production." Annals of the New York Academy of Sciences 795, no. 1 Interleukin 1 (1996): 13–25. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52651.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

BLISS, JUDY, RICHARD MAYLOR, KEYA STOKES, KRISTIN S. MURRAY, MARA A. KETCHUM, and STANLEY F. WOLF. "Interleukin-12 as Vaccine Adjuvant." Annals of the New York Academy of Sciences 795, no. 1 Interleukin 1 (1996): 26–35. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52652.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Podlaski, Frank J., Venkata B. Nanduri, Jeffrey D. Hulmes, et al. "Molecular characterization of interleukin 12." Archives of Biochemistry and Biophysics 294, no. 1 (1992): 230–37. http://dx.doi.org/10.1016/0003-9861(92)90162-p.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Trinchieri, Giorgio, Manthrasalam Rengaraju, Annalisa D'Andrea, et al. "Producer cells of interleukin 12." Parasitology Today 9, no. 3 (1993): 97. http://dx.doi.org/10.1016/0169-4758(93)90215-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Brunda, Michael J., and Maurice K. Gately. "Antitumor Activity of Interleukin-12." Clinical Immunology and Immunopathology 71, no. 3 (1994): 253–55. http://dx.doi.org/10.1006/clin.1994.1081.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Karp, Christopher L. "Interleukin-12: Amiss in MS." Annals of Neurology 45, no. 6 (1999): 689–92. http://dx.doi.org/10.1002/1531-8249(199906)45:6<689::aid-ana1>3.0.co;2-m.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Gately, Maurice K., Louis M. Renzetti, Jeanne Magram, et al. "THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses." Annual Review of Immunology 16, no. 1 (1998): 495–521. http://dx.doi.org/10.1146/annurev.immunol.16.1.495.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Wang, Xin, Victoria L. Wilkinson, Frank J. Podlaski, et al. "Characterization of mouse interleukin-12 p40 homodimer binding to the interleukin-12 receptor subunits." European Journal of Immunology 29, no. 6 (1999): 2007–13. http://dx.doi.org/10.1002/(sici)1521-4141(199906)29:06<2007::aid-immu2007>3.0.co;2-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Yücel, Özlem Özer, Ezel Berker, Semra Gariboğlu та Harika Otlu. "Interleukin-11, interleukin-1β, interleukin-12 and the pathogenesis of inflammatory periodontal diseases". Journal of Clinical Periodontology 35, № 5 (2008): 365–70. http://dx.doi.org/10.1111/j.1600-051x.2008.01212.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

GATELY, MAURICE K., DAISY M. CARVAJAL, SUZANNE E. CONNAUGHTON, et al. "Interleukin-12 Antagonist Activity of Mouse Interleukin-12 p40 Homodimer in Vitro and in Vivo." Annals of the New York Academy of Sciences 795, no. 1 Interleukin 1 (1996): 1–12. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52650.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Robinson, Cory M., and Gerard J. Nau. "Interleukin‐12 and Interleukin‐27 Regulate Macrophage Control ofMycobacterium tuberculosis." Journal of Infectious Diseases 198, no. 3 (2008): 359–66. http://dx.doi.org/10.1086/589774.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!